- Home
- GH vs DRVN Comparison
GH vs DRVN Comparison
Compare GH & DRVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GH
- DRVN
- Stock Information
- Founded
- GH 2011
- DRVN 1972
- Country
- GH United States
- DRVN United States
- Employees
- GH N/A
- DRVN N/A
- Industry
- GH Medical Specialities
- DRVN Automotive Aftermarket
- Sector
- GH Health Care
- DRVN Consumer Discretionary
- Exchange
- GH Nasdaq
- DRVN Nasdaq
- Market Cap
- GH 2.7B
- DRVN 2.7B
- IPO Year
- GH 2018
- DRVN 2021
- Fundamental
- Price
- GH $30.98
- DRVN $16.10
- Analyst Decision
- GH Strong Buy
- DRVN Buy
- Analyst Count
- GH 15
- DRVN 12
- Target Price
- GH $39.93
- DRVN $17.88
- AVG Volume (30 Days)
- GH 2.2M
- DRVN 702.0K
- Earning Date
- GH 11-06-2024
- DRVN 10-31-2024
- Dividend Yield
- GH N/A
- DRVN N/A
- EPS Growth
- GH N/A
- DRVN N/A
- EPS
- GH N/A
- DRVN 0.03
- Revenue
- GH $692,256,000.00
- DRVN $2,329,148,000.00
- Revenue This Year
- GH $31.00
- DRVN $4.04
- Revenue Next Year
- GH $17.55
- DRVN $7.93
- P/E Ratio
- GH N/A
- DRVN $539.81
- Revenue Growth
- GH 29.20
- DRVN 1.71
- 52 Week Low
- GH $15.81
- DRVN $10.59
- 52 Week High
- GH $37.04
- DRVN $16.93
- Technical
- Relative Strength Index (RSI)
- GH 70.13
- DRVN 57.69
- Support Level
- GH $28.45
- DRVN $16.41
- Resistance Level
- GH $32.26
- DRVN $16.79
- Average True Range (ATR)
- GH 1.70
- DRVN 0.42
- MACD
- GH 0.39
- DRVN -0.04
- Stochastic Oscillator
- GH 75.19
- DRVN 61.75
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About DRVN Driven Brands Holdings Inc.
Driven Brands Holdings Inc is an automotive services company in North America. Its platform provides high-quality services to an extensive range of retail and commercial customers. The company provides an extensive range of core consumer and commercial automotive needs, including paint, collision, glass, and repair services, as well as a variety of high-frequency services, such as oil changes and car washes.